#IBB Top 5 Holdings


12-Nov-2017 21:53 PM



      iShares Nasdaq Biotechnology ETF (IBB:NASDAQ), for year-to-date performance up +17.64% and one year performance +7.73%. Majority of the gains from IBB came from their top five holdings: Biogen Inc (BIIB), Amgen Inc (AMGN),  Gilead Sciences Inc (GILD), Regeneron Pharmaceuticals Inc (REGN) and Celgene Corp (CELG). Here are IBB top holdings weight

                       Weight %

  1. BIIB        8.48
  2. AMGN     8.48
  3. GILD       7.55
  4. REGN      6.45
  5. CELG       6.29

This graph show their current price pullback from their 52 weeks high

  The difference in percentage (%) from their 52 weeks high are:

  1. BIIB 11%
  2. AMGN 9.81%
  3. GILD 14.48%
  4. REGN  25.57%
  5. CELG   30.55%

Here is a look at #IBB current chart

     Why should you care about this? Well, these are the leaders in the biotech sector, as leaders goes the small cap biotech stocks will follow. This is just our opinion and idea only. We would love to hear your feed back and comment. It's free to sign up. 

Add Your Comment

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.